drugset / Trial / NCT02787824

Periodic Versus Continuous IV Iron Supplementation in HD Patients

NCT02787824

Phase 4 Completed 27 enrolled Papageorgiou General Hospital
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study was to compare the efficacy of two regimens of intravenous iron sucrose \[continuous (in every hemodialysis session) versus intermittent (every 1-4 weeks)\] on the response of rHuEPO in the maintenance phase of its administration in hemodialysis patients.

Timeline

Start
2016-05
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown Intravenous